Hypersensitivity reactions after diagnostic nonvascular administration of iodine-based contrast media and gadolinium-based contrast agents and the role of the drug allergy specialist

被引：1
作者：
van der Molen, Aart J. [1 ]
Vega, Francisco [2 ]
van de Ven, Annick A. J. M. [3 ]
Dekkers, Ilona A. [1 ]
Laguna, Jose J. [4 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Radiol, C-2S,Albinusdreef 2, NL-2333 Leiden, ZA, Netherlands
[2] Hosp Univ Princesa, Dept Allergy, Madrid, Spain
[3] Univ Med Ctr Groningen, Dept Internal Med, Div Allergol, Groningen, Netherlands
[4] Hosp Univ Cruz Roja, Allergy Unit, Allergo Anaesthesia Unit, Madrid, Spain
来源：
EUROPEAN JOURNAL OF RADIOLOGY | 2024年 / 181卷
关键词：
Contrast media/administration and dosage; Drug administration routes; Hypersensitivity; Fluoroscopy; Tomography; X-ray computed; Magnetic resonance imaging; IMMEDIATE HYPERSENSITIVITY; ADVERSE-REACTIONS; LOW-OSMOLAR; ANAPHYLACTOID REACTION; RADIOCONTRAST MEDIA; COMPUTED-TOMOGRAPHY; RENAL EXCRETION; SKIN-TESTS; CORTICOSTEROID PROPHYLAXIS; GADOPENTETATE DIMEGLUMINE;
D O I：
10.1016/j.ejrad.2024.111803
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The risk of hypersensitivity reactions (HSR) following nonvascular administration of contrast media (CM) for diagnostic studies is very low, likely due to minimal absorption into the systemic circulation. Most published individual cases of HSR after nonvascular CM administration are immediate reactions caused by ionic highosmolar CM, few by nonionic low-osmolar CM, and none by gadolinium-based contrast agents. Measures to prevent recurrent HSR following nonvascular administration are similar to those recommended to prevent HSR after intravascular CM administration. Premedication as preventive measure has been abandoned, while switching to an alternative CM, preferably based on the results of an allergological analysis, is increasingly advocated. In selected scenarios, preventive measures may be minimized.
引用
收藏
页数：10
相关论文
共 50 条
  • [41] Gadolinium retention after administration of contrast agents based on linear chelators and the recommendations of the European Medicines Agency
    Dekkers, Ilona A.
    Roos, Rick
    van der Molen, Aart J.
    EUROPEAN RADIOLOGY, 2018, 28 (04) : 1579 - 1584
  • [42] Acute adverse reactions to radiographic iodinated and gadolinium-based contrast media: incidence, risk factors and premedication: From published evidence to a practical approach
    Tonolini, M.
    Bianco, R.
    CLINICA TERAPEUTICA, 2011, 162 (06): : 591 - 594
  • [43] Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's adverse event reporting system and review of case reports in the literature
    Raisch, Dennis W.
    Garg, Vishvas
    Arabyat, Rasha
    Shen, Xian
    Edwards, Beatrice J.
    Miller, Frank H.
    McKoy, June M.
    Nardone, Beatrice
    West, Dennis P.
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (01) : 15 - 23
  • [44] Risk factors for post-contrast acute kidney injury in patients sequentially administered iodine- and gadolinium-based contrast media on the same visit to the emergency department: a retrospective study
    Kang, Changshin
    Han, Soo Hyun
    Park, Jung Soo
    Choi, Dae Eun
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2023, 42 (03) : 358 - 369
  • [45] Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents
    Radbruch, Alexander
    Weberling, Lukas D.
    Kieslich, Pascal J.
    Hepp, Johanna
    Kickingereder, Philipp
    Wick, Wolfgang
    Schlemmer, Heinz-Peter
    Bendszus, Martin
    INVESTIGATIVE RADIOLOGY, 2016, 51 (11) : 683 - 690
  • [46] Evaluation of signal intensity changes in dentate nucleus and globus pallidus on magnetic resonance imaging after intrathecal gadolinium-based contrast agent administration
    Asoglu, Semih
    Kilincer, Abidin
    Ozer, Halil
    Topaloglu, Omer Faruk
    Cebeci, Hakan
    CLINICAL IMAGING, 2024, 109
  • [47] Effects of Height and Blood Volume on Venous Enhancement After Gadolinium-Based Contrast Administration in MR Venography: A Paradigm Challenge and Implications for Clinical Imaging
    Dehkharghani, Seena
    Williams, T. Richard, III
    Qiu, Deqiang
    Saindane, Amit M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2016, 207 (03) : 621 - 627
  • [48] T1 signal intensity in the dentate nucleus after the administration of the macrocyclic gadolinium-based contrast agent gadoterate meglumine: an observational study
    Ramalho, J.
    Semelka, R. C.
    Cruz, J.
    Morais, T.
    Ramalho, M.
    RADIOLOGIA, 2022, 64 (05): : 397 - 406
  • [49] Acute adverse reactions after multiple initially well-tolerated gadolinium-based contrast-enhanced abdomen MRIs in pediatric patients
    Hojreh, Azadeh
    Mulabdic, Amra
    Heilos, Andreas
    Peyrl, Andreas
    Lampichler, Katharina
    Raudner, Marcus
    Tamandl, Dietmar
    Ba-Ssalamah, Ahmed
    Szepfalusi, Zsolt
    PLOS ONE, 2024, 19 (12):
  • [50] The feasibility of superparamagnetic iron oxide-enhanced magnetic resonance imaging for assessing liver lesions in patients with contraindications for iodine CT contrast media or gadolinium-based MR contrast media: a retrospective case-control study
    Kurata, Chishio
    Saito, Kazuhiro
    Shirota, Natsuhiko
    Araki, Yoichi
    Sugimoto, Katsutoshi
    Tajima, Yu
    Yunaiyama, Daisuke
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2022, : 4612 - 4621
12345